Reviva Pharmaceuticals Holdings, Inc. is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize next-generation therapeutics for central nervous system, inflammatory, and cardiometabolic diseases. Its pipeline includes two drug candidates: brilaroxazine (RP5063), a multimodal serotonin, dopamine, and nicotinic receptor modulator in clinical development for schizophrenia, bipolar disorder, MDD, ADHD, PAH, and IPF; and RP1208, in preclinical stage. Both are new chemical entities discovered in-house with composition of matter patents granted in the U.S., Europe, and other countries.
Q2 FY2026 — expected 2026-09-19
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-30 | 2025-12-31 | 0001437749-26-010126 | EDGAR | 93K words |
| 2025-04-03 | 2024-12-31 | 0001437749-25-010791 | EDGAR | 91K words |
| 2024-04-15 | 2023-12-31 | 0001437749-24-011955 | EDGAR | 85K words |
| 2023-03-30 | 2022-12-31 | 0001437749-23-008502 | EDGAR | 80K words |
| 2022-03-15 | 2021-12-31 | 0001437749-22-006332 | EDGAR | — |
| 2021-03-22 | 2020-12-31 | 0001437749-21-006681 | EDGAR | — |
| 2020-05-04 | 2020-02-29 | 0001104659-20-055760 | EDGAR | — |
| 2019-05-22 | 2019-02-28 | 0001144204-19-027771 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-12 | 2026-06-30 | 0001437749-26-027358 | EDGAR | 25K words |
| 2025-11-13 | 2025-09-30 | 0001437749-25-034827 | EDGAR | 27K words |
| 2025-08-14 | 2025-06-30 | 0001437749-25-026967 | EDGAR | 25K words |
| 2025-05-15 | 2025-03-31 | 0001437749-25-017191 | EDGAR | 20K words |
| 2024-11-14 | 2024-09-30 | 0001437749-24-035375 | EDGAR | 25K words |
| 2024-08-14 | 2024-06-30 | 0001437749-24-026571 | EDGAR | 22K words |
| 2024-05-14 | 2024-03-31 | 0001437749-24-016366 | EDGAR | 17K words |
| 2023-11-14 | 2023-09-30 | 0001437749-23-031973 | EDGAR | 20K words |
| 2023-08-14 | 2023-06-30 | 0001437749-23-023686 | EDGAR | 19K words |
| 2023-05-15 | 2023-03-31 | 0001437749-23-014582 | EDGAR | 16K words |
| 2022-11-14 | 2022-09-30 | 0001437749-22-027265 | EDGAR | 18K words |
| 2022-08-15 | 2022-06-30 | 0001437749-22-020538 | EDGAR | 16K words |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-12 | 0001437749-26-027356 | EDGAR | 2K words |
| 2026-03-30 | 0001437749-26-010140 | EDGAR | 3K words |
| 2026-03-19 | 0001437749-26-009063 | EDGAR | 21K words |
| 2026-03-05 | 0001437749-26-006991 | EDGAR | 2K words |
| 2026-01-23 | 0001437749-26-001913 | EDGAR | 2K words |
| 2025-12-23 | 0001437749-25-038602 | EDGAR | 5K words |
| 2025-11-13 | 0001437749-25-034846 | EDGAR | 3K words |
| 2025-10-17 | 0001437749-25-031278 | EDGAR | 1K words |
| 2025-09-26 | 0001437749-25-029951 | EDGAR | 1K words |
| 2025-09-19 | 0001437749-25-029531 | EDGAR | 21K words |
161 total filings indexed. 131 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001742927 |
| Ticker | RVPH |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.revivapharma.com |
| Listed | 2020-12-15 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/RVPH (~200 tokens, structured JSON with cryptographic provenance)